STOCK TITAN

Stonepine reports 7.2% Femasys stake with warrants

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Femasys Inc (FEMY) has a new significant institutional holder group led by Stonepine Capital Management, LLC and related entities, which collectively report beneficial ownership of 625,000 Femasys equity-linked securities, representing 7.2% of the common stock. This position consists of 312,500 shares of common stock and warrants to acquire an additional 312,500 shares, all subject to a 9.99% beneficial ownership limitation. The ownership percentage is calculated using 8,375,027 shares of common stock outstanding as of August 13, 2026. Voting and dispositive power over the 625,000 securities is shared among Stonepine Capital Management, Stonepine Capital, L.P., Stonepine GP, LLC, and Jon M. Plexico, each of whom disclaims beneficial ownership beyond their pecuniary interest.

Positive

  • None.

Negative

  • None.
Beneficial ownership 625,000 securities Total Femasys securities beneficially owned by each reporting person
Common Stock held 312,500 shares Portion of the position in Femasys common stock
Warrants held 312,500 warrants Warrants to acquire Femasys common stock held by the reporting persons
Ownership percentage 7.2% Percent of Femasys common stock class beneficially owned by each reporting person
Shares outstanding 8,375,027 shares Femasys common stock outstanding as of August 13, 2026, used for ownership calculation
Beneficial Ownership Limitation 9.99% Cap on beneficial ownership applicable to the warrants
Shared voting power 625,000 shares Number of shares over which each reporting person has shared voting and dispositive power
Schedule 13G regulatory
"EXHIBIT 99 - AGREEMENT REGARDING JOINT FILING OF STATEMENT ON SCHEDULE 13D OR 13G"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
beneficial ownership limitation financial
"warrants to acquire 312,500 shares of Common Stock, subject to a 9.99% beneficial ownership limitation"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.
shared voting power financial
"Shared Voting Power 625,000.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power financial
"Shared Dispositive Power 625,000.00"
pecuniary interest financial
"disclaims beneficial ownership of shares of Common Stock except to the extent of that person's pecuniary interest"

FAQ

How much of FEMY does Stonepine Capital report owning on this Schedule 13G?

Stonepine Capital and related reporting persons report beneficial ownership of 625,000 Femasys equity-linked securities, representing 7.2% of the common stock, based on 8,375,027 shares outstanding as of August 13, 2026.

What securities tied to FEMY does Stonepine Capital hold?

The reporting persons’ position consists of 312,500 shares of Femasys common stock and warrants to acquire an additional 312,500 shares of common stock, subject to a 9.99% beneficial ownership limitation.

What ownership percentage in FEMY do the Stonepine reporting persons disclose?

Each of Stonepine Capital Management, Stonepine Capital, L.P., Stonepine GP, LLC, and Jon M. Plexico reports beneficial ownership of 7.2% of Femasys’ common stock, calculated using 8,375,027 shares outstanding as of August 13, 2026.

How is voting power over FEMY shares held by Stonepine structured?

Each reporting person has 0 shares with sole voting power and 625,000 shares with shared voting power, and the same split for dispositive power: 0 sole and 625,000 shared.

What is the beneficial ownership limitation on Stonepine’s FEMY warrants?

The warrants held by the reporting persons to acquire 312,500 Femasys shares are subject to a 9.99% beneficial ownership limitation, which restricts exercises that would push their beneficial ownership above 9.99% of the outstanding common stock.

Who ultimately controls the FEMY position reported by Stonepine?

Stonepine Capital Management and Stonepine GP, LLC serve as investment adviser and general partner, respectively, to Stonepine Capital, L.P. Jon M. Plexico is the control person of both entities, and all reporting persons disclaim beneficial ownership beyond their pecuniary interest.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





31447E204

(CUSIP Number)
08/10/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: The securities beneficially owned by the reporting persons consist of (1) 312,500 shares of Common Stock, and (2) warrants to acquire 312,500 shares of Common Stock, subject to a 9.99% beneficial ownership limitation. The percentage reported herein is calculated based on (a) 8,375,027 shares of Common Stock outstanding as of August 13, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ending June 30, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The securities beneficially owned by the reporting persons consist of (1) 312,500 shares of Common Stock, and (2) warrants to acquire 312,500 shares of Common Stock, subject to a 9.99% beneficial ownership limitation. The percentage reported herein is calculated based on (a) 8,375,027 shares of Common Stock outstanding as of August 13, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ending June 30, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The securities beneficially owned by the reporting persons consist of (1) 312,500 shares of Common Stock, and (2) warrants to acquire 312,500 shares of Common Stock, subject to a 9.99% beneficial ownership limitation. The percentage reported herein is calculated based on (a) 8,375,027 shares of Common Stock outstanding as of August 13, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ending June 30, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The securities beneficially owned by the reporting persons consist of (1) 312,500 shares of Common Stock, and (2) warrants to acquire 312,500 shares of Common Stock, subject to a 9.99% beneficial ownership limitation. The percentage reported herein is calculated based on (a) 8,375,027 shares of Common Stock outstanding as of August 13, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ending June 30, 2026.


SCHEDULE 13G



Stonepine Capital Management, LLC
Signature:/s/ Jon M. Plexico
Name/Title:Managing Member
Date:08/31/2026
Stonepine Capital, L.P.
Signature:/s/ Jon M. Plexico
Name/Title:Managing Member of the General Partner, Stonepine GP, LLC
Date:08/31/2026
Stonepine GP, LLC
Signature:/s/ Jon M. Plexico
Name/Title:Managing Member
Date:08/31/2026
Jon M. Plexico
Signature:/s/ Jon M. Plexico
Name/Title:Reporting Person
Date:08/31/2026
Exhibit Information

EXHIBIT 99 - AGREEMENT REGARDING JOINT FILING OF STATEMENT ON SCHEDULE 13D OR 13G.